Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer ImmunosuppressionMatteo Ponzo, Ilaria Cascone, Alba Nicolás‐Boluda et al.|Cancers|2022Cited by 11
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265Matteo Ponzo, Ilaria Cascone, Anaïs Debesset et al.|Cancers|2022Cited by 0
TNFR2 blockade promotes anti-tumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustionAnaïs Debesset, José L. Cohen|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0